Skip to main content

AVKARE Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20152
20173
20187
201912
20207
20211
20221
Download CSV

FDA Recall Terminated Historical recordClass II

AVKARE Ranitidine Hydrochloride Capsules 150 mg 500 Capsules Rx Only NDC 42291-735-50 UPC 342291735507 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Published
November 6, 2019
Distribution
CO and MO

View recall →

FDA Recall Terminated Historical recordClass II

AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mg, 500 Tablets per bottle, NDC 42291-297-50.

by AVKARE Inc.

Reason
Failed Stability Specifications.
Published
September 18, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Losartan Potassium Tablets USP 25 mg 50 tablets (5x10) Unit Dose Rx Only NDC 50268-516-15 Manufactured for: AvKARE Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Losartan Potassium Tablets USP 50 mg 50 tablets (5x10) Unit Dose Rx Only NDC 50268-517-15 Manufactured for: AvKARE Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30

by AVKARE Inc.

Reason
Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)
Published
April 17, 2019
Distribution
AZ and CO

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/12.5 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-514-15

by AVKARE Inc.

Reason
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Published
March 27, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-513-15

by AVKARE Inc.

Reason
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Published
March 27, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15

by AVKARE Inc.

Reason
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Published
March 27, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
Failed Dissolution Specifications
Published
March 20, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%) 7.5fl.oz./222mL refill bags, AvKARE, Inc. Pulaski, TN 38478 www.avkare.com, NDC 5026835427, UPC 3 50268 35408

by AVKARE Inc.

Reason
Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product
Published
December 5, 2018
Distribution
WA only

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit Dose NDC 50268-786-13 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

This page lists recalls that name AVKARE Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.